Skip to Main Content

Paper Details

Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.
Urol Oncol
15
2016
Cas3, Ki-67, Neo, Patients, SFK, SRC-family kinase, abdominal pain, cleaved caspase (Cas)-3, dasatinib, dyspnea, enteric fistula, fatigue, hematuria, miUCB, muscle-invasive bladder cancer, muscle-invasive urothelial carcinoma of the bladder, pSFK, patients, phosphorylated SFK, pulmonary embolism, supraventricular tachycardia, tumor, tumors, urothelial carcinoma
Author NameAffiliation
Beatrice S KnudsenCedars-Sinai Medical Center
Raymond S LanceEastern Virginia Medical School
Christopher L CorlessOregon Health and Science University
Matthew D GalskyMount Sinai School of Medicine Tisch Cancer Institute
Edwin M PosadasCedars-Sinai Medical Center
  • 1 - 5

Datasets

Release 1.2